Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +250 | +326.54% | $0.00 | 327 | Sep 1, 2024 | Direct | F1, F2 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$30.4K | -90 | -27.56% | $337.32 | 237 | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +173 | +73.13% | $0.00 | 410 | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$20.9K | -62 | -15.14% | $337.32 | 348 | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +177 | +50.93% | $0.00 | 525 | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$21.6K | -64 | -12.2% | $337.32 | 461 | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +265 | +57.54% | $0.00 | 726 | Sep 2, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$32K | -95 | -13.09% | $337.32 | 631 | Sep 2, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +217 | +34.41% | $0.00 | 848 | Sep 3, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$26.1K | -78 | -9.2% | $334.31 | 770 | Sep 3, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Sale | -$206K | -623 | -80.96% | $330.49 | 147 | Sep 4, 2024 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -250 | -24.95% | $0.00 | 752 | Sep 1, 2024 | Bio-Rad A Common Stock | 250 | $0.00 | Direct | F4, F5 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -173 | -33.21% | $0.00 | 348 | Sep 1, 2024 | Bio-Rad A Common Stock | 173 | $0.00 | Direct | F4, F6 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -177 | -49.86% | $0.00 | 178 | Sep 1, 2024 | Bio-Rad A Common Stock | 177 | $0.00 | Direct | F4, F7 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -265 | -100% | $0.00 | 0 | Sep 2, 2024 | Bio-Rad A Common Stock | 265 | $0.00 | Direct | F4, F8 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -217 | -100% | $0.00 | 0 | Sep 3, 2024 | Bio-Rad A Common Stock | 217 | $0.00 | Direct | F4, F9 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Includes 45.6820 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.40 to $330.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F5 | On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F8 | On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F9 | On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |